Seasonal Allergic Rhinitis – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Seasonal Allergic Rhinitis – Drugs In Development, 2024 report and make more profitable business decisions.
Seasonal allergic rhinitis (SAR), commonly referred to as hay fever, is an inflammatory condition affecting the upper airways in response to exposure to airborne allergens, typically pollen from trees, grasses, and weeds, particularly prevalent in certain seasons. This condition manifests in sensitized individuals, giving rise to symptoms such as sneezing, nasal congestion, a runny nose, itchy or watery eyes, and fatigue. SAR involves an immune system response, with the release of histamines and other chemicals triggered by exposure to allergens. While SAR itself doesn’t pose a serious health threat, its impact on the quality of life for those affected can be substantial. Management strategies often include allergen avoidance, the use of over-the-counter or prescription antihistamines, nasal corticosteroids, and, in severe cases, allergen immunotherapy.
The Seasonal Allergic Rhinitis drugs in development market research report provide comprehensive information on the therapeutics under development for Seasonal Allergic Rhinitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Seasonal Allergic Rhinitis and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Seasonal Allergic Rhinitis | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 24 molecules, with 23 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Seasonal Allergic Rhinitis therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Seasonal Allergic Rhinitis pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Seasonal Allergic Rhinitis treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Alkem Laboratories LtdAllergy Therapeutics Plc
AOBiome LLC
ARS Pharmaceuticals Inc
Bai Shuo Beijing Pharmaceutical Technology Co Ltd
Changchun Lanjiang Pharmaceutical Technology Co Ltd
Chrysalis BioTherapeutics Inc
Faes Farma SA
FunPep Co Ltd
Glenmark Pharmaceuticals Ltd
Inimmune Corp
Marinomed Biotech AG
Mitsubishi Tanabe Pharma Corp
Nasus Pharma Ltd
Palo Alto pharmaceuticals Inc
Paradigm Biopharmaceuticals Ltd
Regeneron Pharmaceuticals Inc
Revolo Biotherapeutics Ltd
Sedor Pharmaceuticals LLC
Shiga University of Medical Science
Tianchen Biopharmaceutical (Suzhou) Co Ltd
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Seasonal Allergic Rhinitis reports